Adam J. Olszewski

Hematology
593 Eddy St
Providence, RI 02903

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 386 publications

Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.

Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.

Journal: AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
Published: June 19, 2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Journal: Haematologica
Published: April 12, 2026

Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.

Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.

Journal: Blood neoplasia
Published: March 20, 2026

A Real-World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma.

A Real-World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma.

Journal: EJHaem
Published: January 26, 2026

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma.

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Journal: American journal of hematology
Published: January 05, 2026

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Journal: Research square
Published: November 19, 2025

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal: Cancer research communications
Published: October 21, 2025

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2025

A Rare Genital Concomitant Presentation of Extracavitary Primary Effusion Lymphoma and Squamous Cell Carcinoma.

A Rare Genital Concomitant Presentation of Extracavitary Primary Effusion Lymphoma and Squamous Cell Carcinoma.

Journal: Rhode Island medical journal (2013)
Published: September 26, 2025

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Journal: Blood cancer journal
Published: September 13, 2025

SOHO State of the Art Updates and Next Questions | Diagnosis and Management of High-Grade B-Cell Lymphomas.

SOHO State of the Art Updates and Next Questions | Diagnosis and Management of High-Grade B-Cell Lymphomas.

Journal: Clinical lymphoma, myeloma & leukemia
Published: September 02, 2025

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Journal: Blood
Published: September 02, 2025
Showing 1-12 of 386

Last Updated: 09/26/2026